ED, Evidence Generation TA Head - Oncology

Job Description Summary

#LI-Remote

Novartis has an incredible opportunity for a talented individual to join our team as an Executive Director, Evidence Generation TA Head - Oncology. This leadership role will lead an Evidence Generation TA team supporting Oncology, driving a robust evidence generation and communication plan for priority pipeline and marketed assets in the US. In this role, the EG TA leader will be accountable for leading a team of researchers responsible for executing scientifically robust research including, but not limited to real-world/HEOR studies, economic modeling, patient preference studies and non-interventional studies.

The EG leader also be responsible for ensuring the entire US EG teams portfolio of work is reflected in integrated evidence plans. Leads/co-leads development and implementation of Research Collaborations (RCs) for population health initiatives as well as ensures strategic alignment for all US access-related Medical efforts in close collaboration with VEL, Market Access, Medical Directors and other key internal collaborators.

Serves as an EG leader seeking to innovate and create an industry leading function in rigor, impact and efficiency.

This position can be based remotely anywhere in the U.S. (there may be some restrictions based on legal entity). Please note that this role would not provide relocation as a result. The expectation of working hours and travel (domestic and/or international) will be defined by the hiring manager. This position will require 25% travel.

• Value Evidence Development & Execution - Responsible for EG leadership and partnership to develop and lead the implementation of evidence strategies through leadership in the HEOR Oncology. Ensures EG strategy and resulting value story/proposition are strategically aligned, robust, evidence-based, and impactful. Closely collaborates and aligns with Medical Directors, VELs and Market Access across the product portfolio in Oncology, to ensure:
  • Lead team in efficient execution of cross-functional value-evidence strategies, evidence generation & evidence communication plans throughout product lifecycle for US portfolio while ensuring measurable impact of evidence strategy.
  • Collaborate / Lead strategy for, development of, submissions to, and interactions with payer groups, key institutions, regulatory authorities, the HEOR scientific community, technology companies and industry, maintaining expert knowledge on industry and policy trends that may impact patient access and reimbursement for US portfolio
• Accountable for:
  • Quality of the integrated value strategies, evidence generation and evidence communications plans
  • Timely availability of relevant and customized value data
  • Breath/ depth/ quality of technology partnerships established to enhance evidence and value development
  • High Performance of the team to advance US value & reimbursement strategies, plans and execution.
  • Innovation and Change Drive new approaches to bring value to customers through innovations. Evolve strategy to focus on high impact research and analyses and advance overall EG capabilities in alignment with other EG team leads.
  • External Thought Leadership and Partnership Partner with external scientific leaders to drive Evidence Generation strategies. Actively anticipate in shaping the health care environment including key regulatory, reimbursement and value assessment bodies (e.g., FDA, CMS,) as it relates to advancing EG strategies and tactics to address evolving needs. Create strategic advantage and leadership for Novartis with diverse external stakeholders through best-in-class congress participation, workshop participation/presentations, and leadership of scientific/medical exchanges with payers and health systems.
  • Business Partnering - Effectively partner with internal stakeholders regarding research strategies, tactics and outcomes. Ensure execution of research on skills, comprehensive understanding of Novartis business and medical, commercial and access goals, to translate research methodology to diverse audiences. Ensure diverse medical strategies that support payers, patients and providers.
  • P…